severity of symptoms health-related quality of life Symptom Cluster Management Mindfulness Adolescents Leukemia Chemotherapy
Conditions
Interventions
The mindfulness based symptom cluster management program is a behavioral intervention consisting of five sessions delivered over four weeks. It focuses on four self management tasks including medicati
Experimental Behavioral,No Intervention No treatment
mindfulness based symptom cluster management program,control group
Sponsors
None listed
Eligibility
Sex/Gender
All
Age
13 Years to 18 Years
Inclusion criteria
Inclusion criteria: For adolescents with leukemia, the inclusion criteria are 1) having been receiving chemotherapy or planned to receive chemotherapy at the start of induction therapy 2) staying at hospitals with their primary caregiver; 3) no severe depression as indicated by a score of more than 55 in a CDI 4) having a smartphone, social media utilization skills and device, and having Line and Facebook account 5) can read and write in Thai 6) willing to participate in the research project and 7) their primary caregiver agree to participate in the study. For family caregivers, the inclusion criteria are: 1) aged 20-60 years old; 2) staying at hospitals with their adolescents during their treatment; 3) providing unpaid assistance related to the activities of daily living (ADLs); 4) having no formal training to provide such assistance; 5) having a smartphone; 6) can read and write in Thai; and 7) willing to participate in the research project.
Exclusion criteria
Exclusion criteria: Exclusion criteria are 1) having underlying diseases such as Down s syndrome, congenital heart disease, and physical disability as diagnosed by a physician 2) Philadelphia chromosome is presented from bone marrow or peripheral bloodsample collection, utilizing sensitive molecular and cytogenetic techniques conducted by a qualified physician. Discontinuation criteria are 1) not completing at least one session of the intervention 2) having depression before completing the program 3) having severe complications such as sepsis, organ failure before completing the program 4) being transferred to another setting and 5) dying.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| severity of symptoms based line (immediately after program), week4, week 8 after program questionnaires | — |
Secondary
| Measure | Time frame |
|---|---|
| health-related quality of life based line (immediately after program), week 12 after program questionnaires | — |
Countries
Thailand
Contacts
Public ContactWannita Sonkongdang
Chiangmai University
Outcome results
None listed